SHSE:600529's Gross Margin % is ranked better than 78.53% of 382
companies
in the Packaging & Containers industry
Industry Median: 21.38
vs SHSE:600529: 33.44
Shandong Pharmaceutical Glass Co had a gross margin of 32.56% for the quarter that ended in Mar. 2026 => Competition eroding margins
Shandong Pharmaceutical Glass Co (SHSE:600529) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shandong Pharmaceutical Glass Co had a gross margin of 32.56% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shandong Pharmaceutical Glass Co Gross Margin % Related Terms
Shandong Pharmaceutical Glass Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Gross Margin % Chart
SHSE:600529 vs SW, PKG, IP: Gross Margin % Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co Gross Margin % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Gross Margin % of 32.56% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shandong Pharmaceutical Glass Co and its competitors. This is near median its historical median of 32.98. Over the past decade, Shandong Pharmaceutical Glass Co's Gross Margin % has ranged from 26.84 to 36.91. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #82 out of 382 companies in the Packaging & Containers industry, placing it in the top 21.5%.
Is Shandong Pharmaceutical Glass Co's Gross Margin % too high?
Shandong Pharmaceutical Glass Co's current Gross Margin % of 32.56% is near median its 10-year median of 32.98. Over the past 10 years, this metric has ranged from a low of 26.84 to a high of 36.91. The Packaging & Containers industry median Gross Margin % is 21.38. Shandong Pharmaceutical Glass Co's value of 32.56% is 52.3% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #82 out of 382 companies in the Packaging & Containers industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Gross Margin % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #82 out of 382 companies for Gross Margin %. This places Shandong Pharmaceutical Glass Co in the top 22% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 21.38. Shandong Pharmaceutical Glass Co's value of 32.56% is 52.3% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own Gross Margin % has ranged from 26.84 to 36.91 over the past decade. While the company's 10-year median is 32.98 vs. the industry median of 21.38, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Packaging & Containers company?
The median Gross Margin % among Packaging & Containers companies is 21.38, based on 382 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Gross Margin % of 32.56% is 52.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shandong Pharmaceutical Glass Co and its competitors. For the Packaging & Containers industry, the median Gross Margin % is 21.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Gross Margin % is 32.56%, which is near median its own 10-year median of 32.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.12, compared to a current price of ¥18.05 — trading 25.2% below its estimated fair value. The current Gross Margin % is 32.56%, which is near median its 10-year median of 32.98 and 52.3% above the Packaging & Containers industry median of 21.38. Shandong Pharmaceutical Glass Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Gross Margin % is 32.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥18.05 is trading 25.2% below its estimated GF Value™ of ¥24.12.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Gross Margin %: 32.56% (near median its 10-year median of 32.98)
GF Value™: ¥24.12 vs. price of ¥18.05 (25.2% below fair value)
Industry Position: 52.3% above the Packaging & Containers median (#82 of 382)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
89GF Score
Get the complete analysis for SHSE:600529
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
